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Abstract 
Background: matrix metalloproteinase-7 (MMP7), its primary role is to break down extracellular 
matrix including casein, type I, II, IV, and V gelatins, fibronectin, and proteoglycan. The upregulation 
of MMP7 is associated with many malignant tumors. Vimentin (Vim) plays an important role in 
malignant tumors with regard to cellular adhesion, migration and signaling. In our current study, we 
have attempted to evaluate the expression of MMP7 and Vim as markers for aggressive biological 
behavior of AdCC.  Materials and Methods: Nineteen formalin fixed paraffin embedded blocks of 
AdCC were collected retrospectively were included in this study. An immunohistochemical (IHC) 
staining was performed using anti MMP7 and anti Vim monoclonal antibodies. Results: MMP7 
showed significant relation with larger size tumor (P=0.003), higher grade (P=0.006). The Vim was 
significantly correlated with minor salivary gland (P=0.041), larger size tumor (P=0.021), high grade 
(P=0.040).   Both markers revealed highly significant correlation with advanced stage (P<0.001), and 
positive lymph node (LN) (P<0.001). There was a significant positive correlation between Vim and 
MMP7 (P=0.001).Conclusion: Both MMP7 and Vim are positively correlated with tumors of poor 
prognosis.   
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ةصلاخلا 
ةيفمخ:MMP7  .سماخلاو ،عبارلاو يناثلا نيتلايجلا ،لولأا عونلا ،نيزاكلا كلذ يف امب ةيمخلا جراخ ةفوفصملا رسك وه يساسلأا اهرود
 ل يجيسنلا ريبعتلا ةدايز طبتريوMMP7  .ةثيبخلا مارولأا نم ديدعلا عمVim يف مهم رود اهل  ةيمخلا قاصتلاب قمعتي اميف مارولأا
  ريبعت مييقت لواحن ،ةيلاحلا ةساردلا يف .ةرجهلاوMMP7  وVim  ل يجولويبلا يناودعلا كومسمل تاملاعكAdCC. 
داوملا  قرطلاو نييفارابلا عمشب ةرومطمو نيلامروفلاب تبثم جيسن رشع ةعست :يسيك ناطرسك ابجيسن ةصخشم ةدغلاب هيبش مدختسا .
 ريبعت ميقتل ةيجيسنلا ةيئايميكلا ةعانملا ةينقتMMP7  وVim  .لسنلا ةيداحا تاداضمكجئاتنلا ترهظأ :MMP7  ةللاد تاذ ةقلاع
( ةريبكلا مارولاا عمP = 0.003( ايجيسن ةياغمل ةنيابتملاو ، )P = 0.006 طبترا .)Vim ا عم ظوحمم لكشبةريغصلا ةيباعملا ةدغل 
 (P = 0.041، ) ( ةريبكلا مارولااP = 0.021( ايجيسن ةياغمل ةنيابتملاو ،)P = 0.040 نم لك تفشك .)MMP7 و Vim تاملاع
( ايجيسن ةمدقتملا لحارملا عم ةياغمل ريبك طابتراP <0.001، ) ( ةيوافميملا ةدقعلاوP <0.001 ةقلاع كانه ناك ،كلذ ىمع ةولاعو .)
 نيب ةيئاصحإ ةللاد تاذ ةيدرطMMP7و Vim ((P = 0.001. 
 ةصلاخلا لك :MMP 7 وVim .ءيس يضرم لبقتسم تاذ ماروأ عم يباجيإ لكشب ةطبترم 
 
:ةيحاتفملا تاممكلا  ناطرس يسيكةدغلاب هيبشةيجيسنلا ةيئايميكلا ةعانملا ،نيتنيماف ،نيسارتيم ،. 
1. Introduction 
      Adenoid cystic carcinoma (AdCC) was initially described by Bilroth in 1856 and 
named as cylindroma for its classic histologic appearance; this neoplasm underwent 
numerous name changes before being given its current name by Spies in 1930
 
(Jaso 
and Malhotra 2011). Is accounts for 1% of all head and neck  cancers and about 10-
22% of all malignant tumors of the major and minor salivary glands.Minor salivary 
glands (65%) are more frequently involved than major salivary glands (submandibular 
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- 19%, parotid - 16%). Occasionally, they arise from sites other than salivary glands, 
such as the lacrimal glands, the ceruminal glands of external auditory canal, nose, 
paranasal sinus, palate, nasophaynx, and larynx
 
(Gandhi et al., 2015; Spiro et al., 
1974). It is most common in the fifth and sixth decades of life; however, it can appear 
at virtually any age. The patient population review was reported to range from 10 to 
96 years
 
(Da Cruz et al., 2006). Gender predilection is an inconsistent feature in the 
literature with some authors reporting a male predominance and others finding a 
female or no gender predilection (Khan et al., 2001).The clinical course is 
characterized by an initial period of slow and indolent growth that is usually 
asymptomatic. In most cases the tumor goes unnoticed until it has invaded local 
nerves and structures causing varying symptoms depending on location 
 (Da Cruz et al., 2006). Thus, most patients will present with locally invasive disease. 
In a recent review of AdCC of the nasopharynx, 74.3% of patients showed advanced 
disease at the time of initial evaluation (Wiseman et al., 2002). Cervical LN 
metastasis is a rare event; instead, the tumor spreads through a hematogenous route 
with distant metastasis appearing years, even decades, after initial diagnosis (Da Cruz 
et al., 2006; Spiro, 1997). In one recent series, rate of distant metastasis was reported 
as 47.8% with mean time to distant metastasis reported as approximately 5 years
 
(Rapidis et al., 2005). 
      Matrilysin, also known as matrix metalloproteinase-7 (MMP7), pump-1 protease 
(PUMP-1), or uterine metalloproteinase is an enzyme in humans that is encoded by 
the MMP7gene (Quondamatteo et al., 1999). MMP7 is a member of the matrix 
metalloproteinase family consisting of structural-related zinc-dependent 
endopeptidases. The primary role of cleaved/activated MMP7 is to break down 
extracellular matrix by degrading macromolecules including casein, type I, II, IV, and 
V gelatins, fibronectin, and proteoglycan (Yokoyama et al., 2008). MMP7 found to 
potentially involve in tumor metastasis and inflammatory processes
 
(Edman et al., 
2011). The upregulation of MMP7 is associated with many malignant tumors 
including esophagus, stomach, colon, liver, pancreas, and renal cell carcinomas. High 
MMP7 expression facilitates cancer invasion and angiogenesis by degrading 
extracellular matrix macromolecules and connective tissues. Theses degradations are 
associated with many mechanisms including embryogenesis, postpartum uterine 
involution, tissue repair, angiogenesis, bone remodeling, arthritis, decubitus ulcer, and 
tumor metastasis/invasion (Yokoyama et al., 2008). 
      Vimentin (Vim) is a protein that in humans is encoded by the VIMgene. Is a type 
III intermediate filament protein that is expressed in mesenchymal cells
 
 
(Eriksson et al., 2009). Vim is reported as an important mesenchymal marker, and 
plays an important role in epithelial-mesenchymal transition in malignant tumors with 
regard to cellular adhesion, migration and signaling
 
(Ivaska et al., 2007). Several 
investigators have previously shown that Vim is an important marker for the early 
detection of cancer, such as bladder cancer, hepatocellular carcinoma and colorectal 
cancer
  
(Costa et al., 2010; Wong and Luk 2012). In addition, methylation of the VIM 
gene is described as a marker in several malignant tumors, including gastric 
carcinoma, colorectal carcinoma, cervical cancer and bladder cancer
 
(Costa et al., 
2010; Shirahata et al., 2009; Jung et al., 2011). In our current study, we have 
attempted to evaluate the expression of MMP7 and Vim as markers for aggressive 
biological behavior of AdCC . 
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2. Materials and Methods 
      A total of Nineteen retrospective formalin fixed paraffin embedded blocks of 
AdCC were collected pro- and retrospectively from the archives of Oral and 
Maxillofacial Pathology Department, College of Dentistry, University of Baghdad; 
Al-Shaheed Ghazi Hospital; Al-Yarmok Hospital, and Al-Diwaniya Hospital from 
(2010 – 2016). The diagnosis of each case was confirmed by the histological 
examination of   the Hematoxylin and Eosin   stained   sections (Figure 1) by two 
experienced pathologists. Tumor Stages were carried out according to WHO 
classification schema
 
(Seifert and Sobin, 1991), while tumor grades were established 
as follows: Grade I (well differentiated), tumors with tubular and cribriform areas but 
without solid components; Grade II (moderately differentiated), cribriform tumors 
that were either pure or mixed with less than 30% of solid areas; and Grade III (poorly 
differentiated), tumors with a predominantly solid pattern
 
(Gnepp, 2009). Four μm 
thick sections were cut for IHC staining with anti MMP7 and Vim Rabbit monoclonal 
antibodies (Abcam UK). Negative and positive controls were included in each IHC 
run. Four normal salivary gland tissues were used as negative external controls, while 
tissue blocks of prostatic carcinoma was used for MMP7, and tissue blocks of breast 
adenocarcinoma was used for  Vim (according to antibodies manufacturer). 
 
 
Figure1: Adenoid Cystic Carcinoma (40X). (H&E) 
 
2.1 Evaluation of IHC Results: 
      The immunoreactions evaluation analyzed according to the presence or absence of 
brown immunostaining in the cytoplasm, however,the intensity of stain was ignored 
because its subjected to individual difference during checking.The expression of both 
markers was evaluated semi-quantitatively. It was obtained by counting the number of 
tumor cells by light microscope in 5 fields (using 40Xobjective in most represented 
areas of sections). Labeling index for each field was calculated using the following 
equation: (number of positive cells/ number of total cells); the mean value of labeling 
indices for the five fields was considered to be the label index for the case. For the 
MMP7 the percentage of positive cells was scored as follows:0 = 0%, score 1= 1-
25%, score2= 26-50%, score 3= 51-75% and score 4= 76-100%
 
(Sugita et al., 2004). 
While for Vim positive cells was scored as follows: 0= negative, score 1=<10%, score 
2= 11–50%, score 3=51–80%, and score 4=>80% positive cells (Liu et al., 2010). 
 
2.2 Statistical analysis 
      Data were analyzed using SPSS (Statistical Package for Social Science; version 
16) and Microsoft Office Excel 2007. Numeric variables were expressed as mean+SD 
(standard deviation) whereas nominal variables were expressed as number and 
percentage. Pearson's Chi-Square test was used to evaluate nominal variable 
frequency difference between groups.Spearman Rank correlation coefficient would be 
used to study correlation between ordinal variables. P-value was considered 
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significant when it was (≤0.05), while the level of (<0.001) was considered highly 
significant. 
 
3. Results 
      The current work included 19 patients with AdCC with a mean age of 
43.11+20.11 years and age range of 25-80 years. Thirteen patients (68.4%) were less 
than 45 years and 6 patients (31.6%) were more than 45 years of age , the majority of 
patients were female (12= 63.2%) whereas male patients accounted for (7= 36.8%). 
The tumor was mostly seen in minor salivary glands (12= 63.2%), and mass lesion 
was the dominant presentation (14= 73.7%). Mean size of tumors was 2.66+1.07 cm 
with a range of (1- 5.5 cm). Table: 1. 
 
Table 1: Clinical characteristics 
Characteristic  N    (%) Mean+SD (range) 
Age (years)  ≤45 years 13 (68.4%) 43.11+20.11 (25-80) 
  >45 years   6 (31.6%)  
Gender  Male   7 (36.8%)  
  Female 
Major 
12 (63.2%) 
  7 (36.8%) 
 
Site 
 
Clinical presentation 
 Minor 
Mass 
Ulcer 
12 (63.2%) 
14 (73.7%) 
  5 (26.3%) 
 
 
 
2.66+1.07 (1- 5.5) 
Size (cm) 
N: Number of cases; SD: Standard deviation 
 
      Histological sections revealed that the majority had moderately differentiated 
morphology (14= 73.7%), followed by well differentiated (3= 15.8%) then poorly 
differentiated morphology (2=10.5%). Positive LN metastasis was seen in 10 patients 
(52.6%) and the majority of patients had stage II disease (6= 31.6%); stage I disease 
was seen in 3 patients (15.8%), stage III was seen in 5 patients (26.3%) and stage IV 
was seen in 5 patients (26.3%).  Table: 2. 
 
Table 2: Stage, grade and LN involvement 
Characteristic N (%) 
   
Grade  Well   3 (15.8%) 
 
Moderate 14 (73.7%) 
 
Poor   2 (10.5%) 
 
LN 
 
Positive 
 
10 (52.6%) 
 
Negative   9 (47.4%) 
  
 
Stage  I   3 (15.8%) 
 
II   6 (31.6%) 
 III   5 (26.3%) 
 IV   5 (26.3%) 
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 Immunohistochemical expression of MMP7, both score 2 and 3 reveled the same 
number and percentage (8 patients =42.1%), whereas 3 patients (15.8%) had score 1. 
The immunohistochemical expression of Vim was distributed as follows: The 
majority of the cases expressed Vim in score 2 (10 patients =52.6%), followed by 
score 1 (6 patients =31.6%) whereas 3 patients (15.8%) had score 3. Table: 3 and 
Figure: 2, 3 and 4. 
 
Table 3: Immunohistochemical expression score of Vim and MMP7 
  
MMP7 Vim 
Score 
 
N % N % 
1 
 
3 15.8% 6 31.6% 
2 
 
8 42.1% 10 52.6% 
3 
 
8 42.1% 3 15.8% 
Total 
 
19        100% 19     100% 
 
 
 
Figure 2: Immunohistochemical expression score of MMP7 and Vim 
 
  
          
Figure 3: MMP7 immunohistochemical expression (A-40X) (B-100X) 
 
     
A B 
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Figure 4: Vim immunohistochemical expression (A-40X) (B-100X) 
 
      According to Chi-Square test, the immunohistochemical expression of MMP7 was 
positively correlated with larger size tumor (r=0.649, P=0.003), higher grade 
(r=0.506, P=0.006), while highly correlation were registered with advanced stage 
(r=0.780, P<0.001) and positive LN metastasis (r=0.815, P<0.001). The Vim was 
positively correlated with minor salivary gland (r=0.473, P=0.041), larger size tumor 
(r=0.526, P=0.021), high grade (r=0.476, P=0.040), whereas highly significant 
relation recorded with advanced stage (r=0.763, P<0.001), and positive LN 
involvement (r=0.733, P<0.001). Moreover, There was a significant positive 
correlation between Vim and MMP7 (r=0.709, P=0.001). Table: 4. 
 
Table 4: Correlation between score of Vim and MMP7 and clinicopathological 
parameters 
 
Correlation Site Size Stage Grade LN Clinically Vim 
Vim r 0.473 0.526 0.763 0.476 0.733 0.494  
 
P 0.041 0.021 <0.001 0.040 <0.001 0.232  
MMP7 r 0.389 0.649 0.780 0.605 0.815 0.272 0.709 
 
P 0.100 0.003 <0.001 0.006 <0.001 0.259 0.001 
*r: Correlation coefficient; P: level of significance 
 
4. Discussion 
      This study is not a large epidemiological one that expressed the incidence and 
prevalence of different clinico-pathological features of AdCC, therefore the limited 
number and the random selection of the cases according to what is available preclude 
for definitive clinical findings. 
      The primary role of MMP7 is to break down extracellular matrix by degrading 
macromolecules including casein, type I, II, IV, and V gelatins, fibronectin, and 
proteoglycan, and the upregulation of MMP7 was found to associate with many 
malignant tumors
 
(Yokoyama et al., 2008). In our study sample, the tumor cells 
mostly showed MMP7 overexpression in score 2 and 3 (42.1%) respectively, while 
the lowest expression was noted in score 1(15.8%). This is in agreement with the 
finding of Lu et al., 2006. However, in study done by Saarialho-Kere  et  al., 1995 
found  reduced  expression  of  MMP7  in  cancer  cells  and concluded that this may  
be  caused  by  incomplete differentiation,  since  healthy  salivary  gland  tissue  also  
expresses  MMP7.  
      The present study showed that MMP7 is positively correlated with larger size 
tumor and this may be an indication of poor prognosis. This correlation with larger 
size may be explained by the ability of a tumor cell expressing this enzyme for rapid 
degradation of surrounding tissues. This is in harmony with the result of Tanioka et 
al., 2003 which found that overexpression of MMP7 may result in the destruction of 
BA 
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physical barriers surrounding tumor cells and promote the progress of tumor invasion. 
Spiro et al., 1974 reported that tumor size in excess of 3 cm and cervical node 
involvements were highly predictive of distant metastases in 196 AdCC patients. 
      The MMP7 also showed a significant positive correlation with higher grade tumor 
which is probably due to the acquisition of further cellular potential with advancing 
grade due to accumulation of multiple mutation and enhancement of dedifferentiation 
of tumors, which is consistent with previous study (Han et al., 2015), and indicates 
that MMP7 expression is closely related to advanced histological grades.  
      MMP7 was proved, in the present study, to be highly correlated with advanced 
stage and positive LN metastasis and this is a poor marker prognosis. The proposed 
explanation for these correlations is that MMP7 facilitates invasion and angiogenesis 
mechanism which leads to the ability of a cell expressing metalloproteinase to invade 
vascular and lymphatic channels. Similar results were recorded in previous studies
 
(Yokoyama et al., 2008; Lu et al., 2006). 
      In the present study, high Vim overexpression was registered in score 2(52.6%), 
while lowest expression was registered in score 3(15.8%). This result is consistent 
with a literature review
 
(Darling et al., 2002); similar findings have been reported by 
Cavalcante et al., 2007 who concluded that Vim is sensitive immunohistochemical 
marker of myoepithelial cells in salivary gland tumors. 
       Concerning the positive correlation of Vim with minor salivary glands, might be 
explained by the more aggressive behavior of minor salivary gland tumors in 
comparison with major salivary tumors and this may be related to differences in 
anatomical patterns of major and minor salivary glands since minor salivary glands 
are devoid of well-developed connective tissue capsule and subsequently malignant 
tumors will have easier access to the surrounding tissue than the case in well 
capsulated major salivary gland tumors. In other words Vim may be regarded as a 
marker of the invasive capability of the salivary gland AdCC. This is in harmony with 
the result of Chomette et al.,
 
1982, in which 86 out of 117 cases were located in minor 
salivary glands. Contrarily, Eisele and Johns 2001 pointed out that AdCC is most 
common in the submandibular and sublingual glands. 
      The significant positive correlation of Vim with higher grade may be an indication 
of poor prognosis; similarly the highly significant correlations with advanced stage 
and positive LN are markers of poor prognosis. This indicates that Vim plays a role in 
epithelial-mesenchymal transition, in which an epithelial acquires mesenchymal 
properties. This was also observed by Mani et al., 2008 who concluded that epithelial-
mesenchymal transition transformed malignant cells are more motile and can be more 
efficient in invading the surrounding tissues and as a result metastasize to distant 
organs. However, Abdulhussain et al., 2013
 
did not find any significant association 
between Vim expression and the tumor grade or stage, suggested that Vim expression 
may be important in oncogenesis but not in determining the tumor grade or stage. 
Similarly, Spiro, 1997 concluded that cervical LN metastasis is a rare event. Instead, 
the tumor spreads through a hematogenous route with a distant metastasis appearing 
years, even decades, after initial diagnosis. 
      Increased tumor size has been linked to cervical involvement, high recurrence 
rate, and poor prognosis (Woolgar, 2006). In our study the significant positive 
correlation between Vim expression and size of tumor is also an indirect evidence of 
invasive capacity of the tumor; since the larger the tumor, the greater the possibility of 
invasion. However, recent studies suggested that tumor size did not predict nodal 
disease, and it is now widely accepted that tumor depth is more accurate predictor of 
sub-clinical nodal metastasis, local recurrence and survival than tumor size (Woolgar, 
2006; Larsen et al., 2009).  
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      MMP7 score was proved to be positively correlated with Vim. This is an 
indication of the combined ability of a malignant cell to express both markers when 
they undergo down differentiation. These results suggest that MMP7 and Vim may 
contribute in epithelial acquires mesenchymal properties and making the cell more 
powerful in invasion and metastasis. This is in agreement with the findings of Ding et 
al., 2016. In accordance with these figures, Zhu, 2010
 
found that Vim and MMP7 
expression showed a positive correlation (rs = 0.789, P<0.01), and concluded that they 
can be used as a reference indicator of early diagnosis and prognosis. Our study 
supports these findings and concluded that VIM and MMP7 are positively correlated 
with tumors of poor prognosis.   
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